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Although human pathologies have mostly been modeled using higher mammal systems such as mice, the lower vertebrate
zebraﬁsh has gained tremendous attention as a model system. The advantages of zebraﬁsh over classical vertebrate models are
multifactorial and include high genetic and organ system homology to humans, high fecundity, external fertilization, ease of
genetic manipulation, and transparency through early adulthood that enables powerful imaging modalities. This paper focuses on
fourareasofhumanpathologythatweredevelopedand/oradvancedsigniﬁcantlyinzebraﬁshinthelastdecade.Theseareasare(1)
wound healing/restitution, (2) gastrointestinal diseases, (3) microbe-host interactions, and (4) genetic diseases and drug screens.
Importantbiologicalprocessesandpathologiesexploredincludewound-healingresponses,pancreaticcancer,inﬂammatorybowel
diseases, nonalcoholic fatty liver disease, and mycobacterium infection. The utility of zebraﬁsh in screening for novel genes
important in various pathologies such as polycystic kidney disease is also discussed.
1.Introduction
Investigators have long utilized reductionist systems and
animal models to mimic and study basic processes regulating
cellularbiology,organfunction,andhosthomeostasis.While
much work has been accomplished and continues to be
undertaken in higher mammalian systems such as mice,
rats, and rabbits, important discoveries have also been made
using invertebrate systems such as Caenorhabditis elegans
and Drosophila melanogaster. For example, RNA interference
technology was ﬁrst discovered in C. elegans [1], as was
the initial caspase enzyme, caspase-1 (ced-3 in C. elegans)
[2]. Similarly, it was in Drosophila melanogaster that
the innate signaling Toll-like receptors (TLRs) were ﬁrst
identiﬁed via the discovery of the Toll gene, as was its
linkage to the nuclear factor kappa-light-chain-enhancer
of activated B cells (NF-κB) signaling cascade [3]. In the
last ∼15 years, there has been a growing appreciation for
the vertebrate organism Danio rerio (zebraﬁsh) as a tool
to study human disease [4]. As opposed to C. elegans and
Drosophila melanogaster,z e b r a ﬁ s hi sav e r t e b r a t eo r g a n -
ism with physiological and anatomical characteristics of
its higher organism counterparts (see Figure 1 for a dia-
gram of larval zebraﬁsh anatomy), while maintaining the
ease of use of a lower organism. The characteristics of
zebraﬁsh that make them desirable tools for the study of
embryogenesis/development also make them useful for the
study of human pathologies. Zebraﬁsh have a fully mapped
genome (http://www.sanger.ac.uk/Projects/D rerio/), which
hassigniﬁcant homologywiththehumangenome,including
noncoding regions (∼60 per gene globally across all genes)
[5] suggesting that numerous genes involved in human
diseases could be matched in the zebraﬁsh genome. Reverse
(morpholino knock-down, Targeting Induced Local Lesions
in Genome—TILLING [6]) and forward genetic (muta-
genesis, transgenic) approaches are well established and
commonly used to manipulate and characterize zebraﬁsh
gene function.
Zebraﬁsh are highly fecund and breed rapidly; a pair of
zebraﬁsh produces over 100 embryos per clutch that are
usable for larval experiments as early as 3 days post fertiliza-
tion (dpf). These larvae are transparent through 7 dpf, and
this can be extended to up to 9–14 dpf with the addition
of the melanocyte inhibitor phenylthiourea. Moreover, the2 Journal of Biomedicine and Biotechnology
Intestinal track
Tail ﬁn
SB
Eye Ear
Heart
Liver
Muscle
Caudal hematopoietic region Ventral ﬁn
Dorsal ﬁn
Cloaca
Figure 1: Diagram of zebraﬁsh anatomy. A representative image
of a transparent, 6dpf larvae captured with brightﬁeld microscopy.
Organs and anatomical features are denoted in the ﬁgure. SB: swim
bladder. Scale bar is 1mm.
recent generation of transparent adult zebraﬁsh such as
the Casper line adds new imaging possibilities [7]. The
transparency of zebraﬁsh, in conjunction with sophisticated
utilization of ﬂuorescent technology to mark signaling
proteins or cellular entities, allows for powerful time-lapse
imaging of biological and disease processes. Additionally, the
vertebrate zebraﬁsh has many features commonly found in
mammals, including an innate immune system composed
of neutrophils, NK cells, and monocyte/macrophages with
functionality by 48 hours post fertilization (hpf) [8, 9]a n d
an adaptive immune system that is fully functional at 4–6
weeks post fertilization [10] .T h ea d a p t i v ei m m u n es y s t e mi s
highly analogous to that of mammals, with T cells and B cells
that have Rag-dependent V(D)J recombination (reviewed
extensively in [9]). Finally, the zebraﬁsh research community
beneﬁts from an up-to-date database of techniques, genetic
strains, and other useful resources at http://zﬁn.org/.
In this paper, we focus our discussion on larval and adult
zebraﬁsh models that recapitulate human diseases, focusing
on four separate branches of pathology: wound heal-
ing/restitution, gastrointestinal disease, microbe-host inter-
actions, and genetic diseases and drug screens.
2. Wound Healing/Restitution
Wound healing represents a critical biological response of
injured tissues and organs. Events causing epithelial injury
and barrier breakdown initiate a biological response known
as “restitution”, which is aimed at resealing the damaged
region and reestablishing host homeostasis. This “wound
healing” response involves migration of epithelial cells
toward the injured regions as well as epithelial cell prolifer-
ation to replenish the cell pool. Understanding the cellular
and molecular mechanisms regulating this response could
have profound translational impact for patients suﬀering
from chronic inﬂammation, ischemia/hypoxia, burn injury,
and cancer. The powerful imaging modalities available to
zebraﬁsh researchers alongside their ease of genetic manip-
ulation make this vertebrate system an ideal model for
studying wound healing response to various injuries [11].
Additionally, the ability of zebraﬁsh to regenerate both limbs
and cardiac tissue [12] makes them a powerful animal model
for understanding the molecular mechanisms involved in
regenerative signaling.
The most popular zebraﬁsh injury model is the larval
tail wounding model, where a segment of the tail ﬁn is
resected. Using this injury model with transgenic zebraﬁsh
expressing EGFP under the transcriptional controlled of
the neutrophil-speciﬁc myeloperoxidase (MPO) promoter—
Tg(BACmpx:GFP)i114—investigators studied real-time neu-
trophil chemotaxis to the site of injury [13]. In this study,
they observed retrograde chemotaxis of neutrophils toward
the vasculature alongside where injury resolution was ob-
served, suggesting for the ﬁrst time that retrograde chemo-
taxis may play an important role in the resolution phase of
the inﬂammatory response [13]. To determine the function
of the reactive oxygen species H2O2 in the wound healing
response, investigators injected mRNA encoding for the
hydrogen peroxide sensor HyPer to one-cell stage developing
zebraﬁsh embryos [14]. Upon tail wounding of 3dpf larvae,
the HyPer sensor demonstrated increased H2O2 production
along a gradient decreasing away from the wound site,
which signaled leukocyte chemotaxis to the injured location
[11]. Using pharmacological and morpholino blockade,
the authors showed that generation of the H2O2 gradient
is dependent on the activity of the dual oxidase (duox)
gene. This HyPer reporter system has also been utilized in
the study of neuronal regeneration, an important area of
study for the treatment of many human diseases. H2O2
produced by injured keratinocytes was shown to induce
somatosensory axonal regeneration in zebraﬁsh. Similar to
the tail ﬁn wounding model, neuronal regeneration required
activation of duox [15]. Moreover, H2O2 administration
promoted axonal regeneration following neuronal injury,
even without accompanying keratinocyte injury [15]. These
results expand the understanding of posttraumatic nerve
injury and subsequent loss of limb function in humans.
The healing-enhancing properties of H2O2 have since been
extended to studies in both rabbits [16] and horses [17]a s
well as one reported case study in a human patient [18].
Beyond cutaneous wounds, zebraﬁsh have been used for
the ability to regenerate cardiac tissue. Unlike mammals,
whichformscarsanddonotregeneratecardiactissuefollow-
ing injury, zebraﬁsh are able to fully regenerate their heart
within 2 months after 20% ventricular resection [19]. This
abilityforzebraﬁshtoovercomescarformationrequiresacti-
vation of Mps1, a mitotic checkpoint kinase [19]. Addition-
ally, cardiac regeneration involves upregulation of wound
healing genes and proliferative factors including apoeb, vegcf,
and granulina (all of which have human analogs) and likely
activation of platelet-derived growth factor B signaling [20].
Cardiac regeneration studies in zebraﬁsh could produce
novel paradigms and identify unique pathways/targets with
profound translational impact for patients suﬀering from
ischemic heart disease.
3.GastrointestinalDiseases
The zebraﬁsh gastrointestinal system is highly homologous
tothatofmammals,containingaliver,pancreas,gallbladder,
and a linearly segmented intestinal track with absorptive
and secretory functions [21, 22]. The intestinal epithe-
lium displays proximal-distal functional speciﬁcation andJournal of Biomedicine and Biotechnology 3
Table 1: Zebraﬁsh gastrointestinal models of pathology.
Model Mechanism of pathology Human relevancy/key features Key references
Pan-GI neoplasias Heterozygotic APC mutation
APC mutations drive spontaneous
and genetic intestinal
adenocarcinomas.
Haramis et al., 2006 [24]
Hepatocellular carcinoma Thioacetamide ±
HCV-core-protein-zebraﬁsh
Human genetic overlap. Rising
prevalence of HCV-driven HCC in
humans.
Lam and Gong, 2006 [25]
Rekha et al., 2008 [26]
Pancreatic cancer Transgenic ptf1a-KRAS zebraﬁsh
Recapitulates hedgehog signaling
aberrations found in humans.
Elucidates a potential cellular origin
for pancreatic cancers.
Park et al., 2008 [27]
Inﬂammatory bowel disease TNBS in the media of zebraﬁsh
larvae
Model inﬂammatory and goblet
cell hypertrophy. Responds to
bacterial status and IBD
medications.
Flemming et al., 2010 [28]
Oehlers et al., 2011 [29]
Inﬂammatory bowel disease Oxazolone enema in adult
zebraﬁsh
Goblet cell depletion and eosinophil
inﬁltration. Responds to antibiotic
therapy.
Brugman et al., 2009 [30]
NAFLD
Mutation in a novel gene:
foigrhi1532b.
Alternative model involves
chemical induction with
thioacetamide
Large lipid ﬁlled hepatocytes and
cellular apoptosis; pathology linked
to ER stress responses. Alternative
model generates a fatty liver and
hepatocyte apoptosis.
Cinaroglu et al., 2011 [31]
Amali et al., 2006 [32]
(alternative model)
Alcoholic liver disease 2% ethanol to the water of 4dpf
zebraﬁsh for 32 days
Hepatomegaly and steatosis, with
upregulation of genes involved in
toxic alcohol metabolism. Model is
sensitive to sterol regulatory
binding protein, important in
human disease.
Passeri et al., 2009 [33]
Abbreviations: GI: gastrointestinal; APC: adenomatous polyposis coli; HCV: hepatitis C virus; TNBS: 2,4,6-trinitrobenzene sulfonic acid; IBD: inﬂammatory
bowel diseases; NAFLD: nonalcoholic fatty liver disease; ER: endoplasmic reticulum.
contains many of same epithelial cell lineages found in
mammals including absorptive enterocytes, goblet cells, and
enteroendocrine cells [21, 22]. Enterocytes have a basolateral
nuclei and form tight junctions, apical microvilli, and an
intestinal brush border [23]. In the last decade, numer-
ous gastrointestinal pathologies have been modeled in the
zebraﬁsh, as summarized in Table 1.
Interestingly, a forward genetic mutagenesis screen (N-
ethyl-N-nitrosourea (ENU), see section ﬁve) generated ze-
braﬁsh mutants that develop spontaneous intestinal, pan-
creatic, and hepatic neoplasias [24]. These mutants were
later found to be heterozygotic for a truncated form of
APC, thereby leading to accumulation of nuclear β-cate-
nin and increased expression of downstream genes such
as cmyc and axin2 [24]. Adding the carcinogen 7, 12-
dimethylbenz[a]anthracene to these mutant zebraﬁsh in-
creases the frequency of tumor development. Since germ-
line-truncated APC mutations in both humans [34, 35]a n d
mice [36] result in the spontaneous development of a large
numbers of intestinal polyps, the APC zebraﬁsh model could
be useful in genetic, drug screening, and toxicology studies.
There are roughly 24,000 new cases of hepatocellular
carcinoma (HCC) annually in the United States, resulting
in over 18,000 deaths per year [37]. Worldwide, the disease
incidence can be as much as 30-fold higher due to the
increased prevalence of hepatitis infections [38]; globally
estimated 564,000 new cases occur per year, accounting for
5.6% of all human cancers [38], and resulting in similar rates
of mortality as seen in the USA [38]. Oncogenomic proﬁling
of liver tumors showed a signiﬁcant overlap between human
and zebraﬁsh in 132 genes [25]. These genes included those
involved in β-catenin and Ras-MAPK signaling pathways
as well as genes implicated in cellular adhesion, apoptosis,
and liver-speciﬁc metabolism found in both organisms [25].
HCC can be induced in zebraﬁsh with the liver toxin
thioacetamide,resultinginHCC-relatedpathologywithin12
weeks of exposure. The timeline of thioacetamide-induced
HCCcouldbesigniﬁcantlyaccelerated(6versus12weeks)by
using transgenic ﬁsh expressing the hepatitis C virus (HCV)
core protein (HCP-transgenic ﬁsh) [26]. The increasing
prevalence of HCC in humans has been attributed to the rise
of HCV infection [39], in particular through the oncogenic
action of the HCV core protein [40], making this model
particularly relevant to human disease.
Pancreatic cancer represents the fourth most common
cause of cancer-related mortality in the western world, likely
due to limited diagnostic tools and inability to survey the
disease. Exocrine pancreatic cells are responsible for more4 Journal of Biomedicine and Biotechnology
than 95% of pancreatic cancer [37]. The cell population in
the pancreas that gives rise to human exocrine pancreatic
cancer remains unknown and investigators have turned to
zebraﬁsh models to investigate this important question.
Transgenic zebraﬁsh were generated using a bacterial arti-
ﬁcial chromosome (BAC) approach that expressed EGFP-
KRAS fusion protein under the control of the zebraﬁsh
pancreatic locus ptf1a (Tg(pft1a:EGFP-Hsa.KRASG12V)jh7
[27]. Using these ﬁsh, investigators found that while normal
pancreatic cell progenitors diﬀerentiated normally, KRAS-
transgenic ﬁsh had blocked cellular diﬀerentiation, produc-
ing a pool of undiﬀerentiated progenitors that progressed to
invasive pancreatic cancer over a course of 3 to 9 months.
These cancer cells also had increased expression of multiple
hedgehog genes (shh, dhh, ihha, ihhb)a sw e l la st h ed o w n -
stream hedgehog targets Ptc2, ptc1,a n dgli1. This aberrant
signaling pattern seen in these pancreatic tumor cells was
also typical of human pancreatic cancer [27]. This zebraﬁsh
model established for the ﬁrst time that oncogenic exocrine
pancreatic progenitor cells could be the cellular origin for
pancreatic cancer.
Outside of cancer models, one area of gastrointestinal
disease that has received signiﬁcant attention in recent years
is the development of zebraﬁsh models of Inﬂammatory
Bowel Disease (IBD). In humans, IBD is the result of dysreg-
ulatedinteractionsbetweenageneticallysusceptiblehostand
their commensal gut microbiota [41–43]. IBD is primarily a
disease of the Western world; it aﬀects 1.4 million Americans
and there is no cure for the disease [44]. Outside of North
America, similar disease burdens are seen in Europe but are
∼3-foldlowerinAsiaandtheMiddleEast,withtheexception
of Japan [45]. Pharmacological treatment centers around the
use of anti-inﬂammatories and immunosuppressants, and
surgical management of the disease is also possible though
not always curative [46]. Numerous chemicals and genetic
approaches are currently used by the IBD research commu-
nity to study this pathology. These models mimic various
aspects of the disease, such as disrupted barrier function
and impaired innate and adaptive immune responses [47,
48]. Among the chemical models, the hapten oxazolone has
been used for studies of acute intestinal inﬂammation. This
murine model consists of rectal administration of a single
dose of oxazolone dissolved in ethanol, resulting in an acute
colitislastingupto10days,withpeakinﬂammationat2days
post administration in mice [49]. The model is characterized
by a strong Th2-dependent immune response that can be
abrogated by IL-4 neutralizing antibodies and has similar
characteristics to human ulcerative colitis [48].
Investigators have tried to adapt the hapten oxazolone
model of colitis to adult zebraﬁsh. Brugman et al. showed
intestinal epithelial damage and goblet cell depletion in
oxazolone-treated ﬁsh within 5 hours of treatment, which
lasts for up to 7 days [30]. This was accompanied by eos-
inophil inﬁltration into the intestine with increased il1b, tnf,
and il10 gene production compared to untreated zebraﬁsh.
The inﬂammatory phenotype was reduced by the adminis-
tration of the gram-positive-speciﬁc antibiotic vancomycin,
suggestingaroleforcommensalbacteriaintheinﬂammatory
process of this model. The main constraint of this model
is the need to use adult, nontransparent zebraﬁsh which
severely limits imaging capability. In addition, the need to
rectally administer each individual zebraﬁsh with oxazolone
represents a technical challenge.
Thehapten2,4,6-trinitrobenzenesulfonicacid(TNBS)is
another popular mammalian model of colitis characterized
by a Th1-driven immune response [48] that is used for the
study of both acute and chronic intestinal inﬂammation. In
the acute model, TNBS is dissolved in ethanol and rectally
administered in a single dose, while the chronic model can
have multiple administrations weekly over a period of
months [50]. The ethanol is responsible for disrupting the
intestinal barrier while the TNBS serves to activate the
immune system [48]. Two research groups have developed
a larval model of colitis by exposing 3dpf zebraﬁsh for 3–
5d a y st oT N B Si nt h eﬁ s hm e d i a[ 28, 29]. Using the MPO
reporter strain (Tg(BACmpx:GFP)i114) these investigators
noticedneutrophilinﬁltrationthroughoutthezebraﬁsh[13],
gut-speciﬁc increases in il1b expression, altered intestinal
lipid metabolism, goblet cell hypertrophy, and intestinal
shortening. This larval TNBS model presents several advan-
tages, including a dose-dependent phenotype, a sensitivity to
antibiotics treatment, and a response to anti-inﬂammatory
agents(5-ASAandprednisolone)widelyusedtotreathuman
IBD[29].However,theintestinal histopathologies arepoorly
characterized in this model. In addition, the inﬂammatory
component appears mostly to be nonintestine speciﬁc. Fur-
thermore, no intestinal epithelial cell damage is observed
histologically [29], suggesting a lack of signiﬁcant intestinal
injury. Finally, it is unclear how a hapten could cause an
inﬂammatory reaction in larvae missing a functional adapt-
ive immune system.
We have recently established a model of epithelial injury
in zebraﬁsh using the NSAID glafenine [51]. Administration
of glafenine to 5dpf zebraﬁsh for 12 hours results in a
dramatic increase in intestinal epithelial cell apoptosis. This
intestinal-speciﬁc apoptotic response is mediated by induc-
tion of endoplasmic reticulum (ER) stress and is accompa-
nied by attenuation of the unfolded protein response (UPR)
coupled to an improper activation of downstream UPR
mediators such atf6 and s-xbp1. Interestingly, loss of XBP1 in
IECs results in the development of spontaneous enterocolitis
in mice [52] and polymorphisms of this gene are associated
with human IBD [53].
Chronicliverdiseaseisresponsibleforover25,000deaths
annually in the United States and represents the tenth
leading cause of death, with a prevalence of over 5.5 million
patients in 1998 [54] and that has since been estimated to
aﬀect up to 30% of the US population [55]. In the UK,
the picture is grimmer, as it is the ﬁfth leading cause of
death [56]. Nonalcoholic fatty liver disease (NAFLD) is a
highlyprevalentformofseverechronicliverdisease,aﬀecting
3% of all adults in America [57]. It also has signiﬁcant
associated mortality, with a 5-year survival of 67% and 10-
year survival of 59% [57]. Additionally, up to one-third
of all Americans have some level of NAFLD [56]. Outside
of the USA, where obesity is less prevalent, rates are also
increasing. In Italy, which is traditionally considered low
risk, an incidence of NAFLD of 20–25% of the populationJournal of Biomedicine and Biotechnology 5
has been recently been reported [56]. In China and Japan,
the disease incidence has been reported at 15% and 14%
of the population, respectively [56] .T h e r ei sn oi d e n t i ﬁ a b l e
cause of NAFLD, but the pathology is linked to obesity,
diabetes, and hyperlipidemia. Treatment involves managing
thesecomplexetiologies,andpharmacologicaltherapiesspe-
ciﬁc for NAFLD are not available for these patients [57].
Consequently, signiﬁcant work has been invested to develop
reliable zebraﬁsh larvae models of liver pathology that could
be easily utilized for drug targeting and screening.
The most characterized zebraﬁsh model of NAFLD
involved a forward genetic screen using viral insertion and
screeningforhepatomegaly.InthecaseoftheNAFLDmodel,
a 172bp gene trap cassette was found to be inserted in the
intron between exons 11 and 12 of the recently discovered
zebraﬁsh gene foie gras (foigr)[ 58], which results in a
frame shift mutation, and generation of a stop codon. This
mutation (foigrhi1532b) results in the development of steatosis
(fattyliverdisease)resemblinghumanNAFLD,characterized
by large lipid ﬁlled hepatocytes and cellular apoptosis in
larvae as young as 5dpf [58]. However, the exact function of
this gene, which is highly conserved across species including
humans, is not yet determined. Further studies with the foigr
mutant have shown that the apoptosis observed involves
increased ER stress and is regulated in part through the
UPRgeneatf6.Morpholinoblockadeofatf6 amelioratesliver
injury during chronic ER stress in the foigr mutants [31].
However, atf6 blockade potentiates steatosis during acute
ER stress induced by the toxin tunicamycin [31], suggesting
that atf6 may have variable eﬀects in diﬀerent phases
(acute/chronic) of liver injury. Hepatic steatosis has also
been induced in zebraﬁsh larvae using thioacetamide [32].
Investigators have showed that administration of 0.025%
thioacetamide into the ﬁsh media at 3dpf resulted in liver
damage by 5dpf, characterized by increased accumulation
of fatty droplets, hepatocyte apoptosis, and upregulation
of apoptotic genes such as bad, bax, p-38a, caspase-3 and
8,a n djnk-1. Overall, the availability of NAFLD zebraﬁsh
models is burgeoning, and they are poised to be screened
for pharmacological compounds that could for the ﬁrst time
eﬀectively treat this disease.
Alcoholic fatty liver disease (ALD) is estimated to be
involved in over 50% of all deaths due to liver failure second-
ary to liver cirrhosis, but accurate estimates for prevalence
are unavailable [54]. Binge drinking leads to transient fatty
liver disease, but chronic alcohol consumption can lead to
ﬁbrosis, cirrhosis, and steatohepatitis [59]. An ALD model
has also been developed in zebraﬁsh with administration
of 2% ethanol to the water of 4 dpf zebraﬁsh for 32
days. This regimen results in hepatomegaly and steatosis,
alongside upregulation of hepatic cyp2e1, sod,a n dbip
gene expression—indicating hepatotoxic metabolism of the
ethanol [33]. Importantly, ethanol-induced steatosis was
prevented by morpholino blockade of the sterol regula-
tory binding protein (Srebps). Because Srebps activation is
important in chronic alcoholic liver disease [33]i nh u m a n s ,
the zebraﬁsh ALD model could be utilized to identify
new therapeutic mechanisms and to screen for therapeutic
agents.
4. Microbe-HostInteractions
The ability to generate germ-free and gnotobiotic zebraﬁsh
[60] has led to an increasing interest in understanding cellu-
larandmolecularmechanismsofmicrobial-hostinteractions
using zebraﬁsh. Microbial-host interactions have received
signiﬁcant interested in recent years and have been impli-
cated in a wide variety of human diseases, including CRC
[61], IBD [42, 43], obesity and diabetes [62], intestinal heal-
ing [63], irritable bowel syndrome [64], and inﬂammatory
nociception [65]. Zebraﬁsh are host to gram-positive and
gram-negative bacteria, mycobacteria, protozoa, and viruses
[66], also allowing for their use as a model for infectious
diseases.Inmostcases,microorganismsassociatedwiththese
pathologies are not intrinsically pathogenic but are rather
part of the normal, commensal biota. The organ exposed to
the highest amount of microorganisms in the human body is
the gastrointestinal (GI) tract, especially the distal ileum and
colon. Because of the high prevalence of bacteria and bacte-
rialproductsintheGItract,investigatorshavestudiedmech-
anisms controlling homeostasis in the face of such highly
antigenic materials. The zebraﬁsh GI tract also harbors the
highest concentration of bacteria and as such represents an
interesting model to study bacterial/host interactions.
Bacteria and their associated products such as DNA,
RNA, and membrane structures (peptidoglycans, LPS—
lipopolysaccharide)aretypicallydetectedbyaseriesofinnate
sensors that are evolutionary conserved. A survey of the
zebraﬁsh genome has identiﬁed numerous innate sensors
from the TLR and the Nod-like receptor family as well as
their associated signaling pathways [67]. An almost complete
setofTLRs(TLR1-5,7-9,21[68])existinzebraﬁsh,asdothe
intracellular sensors Nod1 and Nod2 [69]. Associated innate
signaling proteins have also been identiﬁed in zebraﬁsh such
as myeloid diﬀerentiation primary response gene (MyD88)
[68, 70], TIR domain-containing adaptor inducing IFN-β
(TRIF) [71], and NF-κB[ 72, 73].
The most studied bacterial product is arguably the gram-
negative-derived LPS. In mammals, LPS is detected by TLR4,
in association with the coreceptors MD2 and CD-14 [74].
Once engaged, TLR4 recruits the adapter protein Myd88
or TRIF to propagate the signal to NF-κB[ 75] and the
interferon responsive factor (IRF) 3, respectively [76]. This
signaling cascade plays a critical role in host response to
microbes and microbial products. As in humans, high doses
of LPS are toxic to zebraﬁsh [77]. Studies using commensal
and germ-free zebraﬁsh established that intestinal alkaline
phosphatase (iap), known to detoxify the endotoxic lipid
moiety A of LPS in mammals, is induced following micro-
bial colonization [77]. Knockout of iap resulted in exces-
sive intestinal neutrophil inﬁltration, a process involving
functional myd88 and tnfr as determined by morpholino
blockade [77].
Another important TLR system is TLR5, which detects
ﬂagellin and activates various signaling pathways including
NF-κB[ 74]. Similarly to mammals, zebraﬁsh detect ﬂagellin
(Salmonella derived in these experiments) to induce multiple
matrix metalloproteinase genes as well as the inﬂammatory
markersil1b,il8,ifn,andcxcl-C1c [78].Morpholinoblockade6 Journal of Biomedicine and Biotechnology
showed that ﬂagellin-induced Il1b and metalloproteinase 9
(mmp9)w e r emyd88 dependent whereas ifn and il8 were
activated through another signaling system [78].
The functions of some of these TLR downstream
signaling adaptors have also been studied in zebraﬁsh. Both
red and green transgenic Myd88 reporter strains such as
Tg(myd88:EGFP)z163 and Tg(myd88-DsRED2)z164 have
been developed [70]. These strains have been crossed to both
macrophage (Tg(lyz:DsRED2)nz50 [79]) and neutrophil
(Tg(BACmpx:GFP)i114 [13]) reporter strains to monitor
myd88 signaling. Studies with these dual-reporter ﬁsh
demonstrated that MyD88 colocalized with both macro-
phages and neutrophils and that these myd88-expressing
leukocytes migrated to wound sites and were involved in
bacterial phagocytosis [70].
Another downstream mediator of LPS signaling, acting
independently of MyD88, is TRIF. While zebraﬁsh TRIF
shares only 32% homology with the human protein, like in
mammalian systems it can induce IFN and NF-κBl u c i f e ra s e -
reporter responses as seen using an overexpression system in
human HEK293T cells [71]. Interestingly TRIF-dependent
gene induction through the TLR4 pathway was found
to be nonfunctional in experiments with adult zebraﬁsh
stimulated with LPS [71]; however, this is to be expected
given that zebraﬁsh TLR4 paralogues (tlr4a and tlr4b)d on o t
recognize LPS [80, 81].
Outside of the TLRs, the intracellular sensors Nod1
and Nod2 are critical innate signaling systems in mammals.
Importantly, Nod2 was the ﬁrst innate signaling molecule to
be genetically linked to Crohn’s disease susceptibility [82].
The exact protective role of Nod proteins in mammals is not
fully understood but defective bacterial killing appears to be
an important factor [82–84]. Both nod1 and nod2 genes are
expressed in IECs and neutrophils of zebraﬁsh. Functional
studies using morpholino blockade showed that Nod2 plays
an important role in setting host antimicrobial properties
[69]. Interestingly, Nod1 or Nod2 depletion resulted in
increased susceptibility to Salmonella infection in a zebraﬁsh
embryonic infection model [69]. This study suggests that the
antimicrobial properties of Nod2 are conserved in zebraﬁsh.
As mentioned previously, NF-κB signaling is an impor-
tant eﬀector pathway downstream of numerous innate
sensorsystems[85].Colonizationofgerm-freeNF-κB;EGFP
reporter zebraﬁsh Tg(NFkB:EGFP)nc1 with a commensal
microbiota induced NF-κB activation and expression of NF-
κBtargetgenesincludingcomplementfactorb(cfb)andserum
amyloid a (saa) in intestinal as well as in extraintestinal
tissues of the GI tract [86]. Activation of NF-κB signaling
in zebraﬁsh indicates an important role of this transcription
factor in maintaining host homeostasis that is conserved
across species. The ability to longitudinally study NF-κB
activation in a cell-type speciﬁc fashion in response to
various microbial stimuli makes the zebraﬁsh a powerful sys-
tem to decipher complex host-microbe interaction. Overall,
the recent development of the aforementioned technologies
makes the study of microbial-host interactions in zebraﬁsh a
burgeoning area of research.
Response to infection is another area of microbial-
host interaction that has received signiﬁcant attention in
zebraﬁsh. The most studied and prominent zebraﬁsh infec-
tious model is the M. marinum model, which is highly
analogous to the human infectious agent M. tuberculosis,
the etiologic agent for Tuberculosis (TB). TB is a growing
epidemic worldwide, with over 83 million cases reported
between 1990 and 1999, resulting in over 3 million deaths
annually [87]. Many strains of the infectious bacteria are
becoming drug resistant, resulting in an increase in global
disease burden, including in the Unites States [88]. Finding
new drugs to combat the ongoing threat of TB is conse-
quently essential, as the disease can no longer be contained
withcurrentmedications[89].CoincubationofM.marinum
with 5hpf embryos results in the formation of macrophage-
driven granulomas within 5dpf [90], a hallmark of TB
pathology. In vivo imaging and macrophage depletion
showed that granulomas, traditionally thought to be a host-
protective mechanism, may in fact be a source of early TB
tissue dissemination by passing M. marinum into uninfected
macrophages during phagocytosis [91, 92]. Consequently,
this system has provided novel insights into the pathological
mechanismsofTBinfectionanditsinteractionswiththehost
immune system and is poised to be used as a drug screen to
identify novel anti-TB compounds.
Other pathogens have also been studied in zebraﬁsh.
These include S. aureus, S. pyogenes,a n dS. typhimurium.
These and other infectious models in zebraﬁsh have recently
been reviewed in detail by Meeker and Trede [9]. Although
very informative, these studies were not performed using a
natural route of infection but rather by using direct delivery
(injection) into embryos at various developmental stages.
However, oral gavage technology in larvae would likely
improvethephysiologicalrelevanceofinfectiousmodelsper-
form in zebraﬁsh. Another limitation of zebraﬁsh infection
models is the diﬀerence in host temperature; zebraﬁsh and
their natural pathogens exist at a temperature of 28◦C, while
many human-relevant pathogens are only infectious at 37◦C
[9]. Finally, there is some evolutionary divergence in TLR
signaling that must be taken into account when working
withthisorganism.Speciﬁcally,incontrasttomammals,LPS
is not sensed by zebraﬁsh TLR4 and the sensor negatively
regulates MyD88 signaling [80]. Despite these limitations,
zebraﬁsh remain a powerful tool for studying microbe-host
interactions [67].
5. GeneticDiseasesand DrugScreens
Because of their high fecundity, transparency, and ease
of imaging, zebraﬁsh are particularly well suited for
genetic screening approaches. Forward and reverse genetic
approaches can be undertaken to generate new zebraﬁsh
phenotypes and identify new genes of interest with potential
relevance to human disease phenotypes. Zebraﬁsh disease
models can also be screened in a cost- and time-eﬀective
manner to discover disease-suppressing compounds. Using
a whole organism is a particularly appealing aspect of
zebraﬁsh-based screens, since complex cell-cell and organ-
organ interactions are kept intact.
There are two main approaches to forward-genetic
screens in zebraﬁsh that have been undertaken thus far. TheJournal of Biomedicine and Biotechnology 7
ﬁrstinvolvesexposingmalestothemutagenethylnitrosourea
(ENU) and then screening for a phenotype [93, 94] shared
by all mutants, such as renal cysts or heart failure. ENU
is an alkylating agent that typically induces A→Tb a s e
transversions. Zebraﬁsh are relatively resistant to the ENU
toxic side eﬀects, allowing for higher dosages and thus
increased rates of mutation [95]. An alternative mutagenesis
approach employs random retroviral insertion [96, 97].
While this retroviral method is only one-ninth as eﬃcient at
generating a mutation as the ENU approach, it circumvents
the need for positional cloning by tagging each insertion
event, saving signiﬁcant screening eﬀort once a phenotype
is found.
Duchenne muscular dystrophy (DMD) aﬀects 1 in 3500
males and causes progressive muscle degeneration that can
lead to death. DMD is the result of mutations in the sarcolem-
mal protein dystrophin located on the X-chromosome [98].
During an ENU screen of zebraﬁsh [94], a mutation referred
toassapje[99]wasdiscovered.Thismutationwaslaterfound
to be located in the zebraﬁsh Duchenne muscular dystrophy
(dmd) gene and causes progressive muscular degeneration
in zebraﬁsh larvae [100]. Electron microscopy showed that
muscular degeneration was the result of failure to form
proper muscle attachments at the myotendinous junction.
This pathological mechanism was hypothesized to occur in
mammals but was lacking concrete evidence, making the
zebraﬁsh a novel system for studying the pathophysiology of
this devastating disease.
The most common form of heritable polycystic kidney
disease (PKD) is autosomal dominant PKD. This disease
aﬀects more than 1 in 1000 live births and approximately
10% of patients with PKD will require kidney transplant
d u et or e n a lf a i l u r e[ 101]. PKD has been linked to defects
in primary cilia formation and function in humans [101].
This disease has also been successfully modeled in zebraﬁsh
by using retroviral insertion mutagenesis and screening for
cystic kidneys in 5dpf larvae [102]. The screen discovered
12 genes whose loss formed cysts in the glomerular-tubular
region, including two already associated with human disease
(vhnf1 and pkd2), demonstrating genetic and phenotypic
homology between humans and zebraﬁsh. Three of the
10 remaining genes are homologues of Chlamydomonas (a
genus of green algae) genes, which encode components of
intraﬂagellar transport particles involved in cilia formation
[102], but have yet to be analyzed in human PKD patients.
The other 7 genes discovered provide completely novel
targets for studying the underlying genetics and mechanisms
of PKD, as many of the genes that can result in PKD remain
unidentiﬁed in humans [101].
Dilated cardiomyopathy (DCM) is the cause of at least
half of the 5.8 million heart failure cases in the USA, typically
resulting from prior heart damage due to a myocardial
infarction or an infection [103]. Worldwide, DCM is the
leading indicator for heart transplant [104], with incidences
to be as high as 9.6 per 100,000 person-years in Europe
[104] and China [105]. DCM results in poor heart function
that eventually leads to death [103]. ENU zebraﬁsh screens
discovered numerous ﬁsh with cardiac abnormalities [93,
106, 107]. Two of these mutants, sih and pickwickm171,w e r e
found to have dilated hearts with thin walls and defective
contractility [108, 109]. Further analysis showed that the sih
(silent heart) mutants had a mutation in cardiac troponin T
gene [108], while the pickwickm171 mutants had a mutation
in the titin gene [109]. Since both of these genes are known
to be important in human DCM, these mutants zebraﬁsh
represent interesting and complementary models to study
this pathology.
All of the aforementioned models demonstrate that
forward genetic screens in zebraﬁsh can generate speciﬁc
phenotypes that are highly homologous to human diseases.
Further analysis of these mutants almost invariability leads
to the identiﬁcation of a gene with high homology and
relevance to corresponding human disease.
Targeted, reverse genetic approaches are also quite suc-
cessful in generating models of disease, especially if a homo-
log exists between the human gene(s) driving the disease and
the zebraﬁsh. One disease that has recently been modeled
in zebraﬁsh using a reverse-genetic approach is Hutchinson-
Gilfordprogeriasyndrome(HGPS),arare(1:4,000,000peo-
ple) premature senescence syndrome that generally results
from sporadic mutations that disrupts conversion of prel-
amin A to mature lamin A [110]. HGPS patients have
markedly aberrant development characterized by lipodys-
trophy, osteolysis that is most pronounced in the cranium,
and coronary dysfunction [110] .T h em e a nl i f ee x p e c t a n c y
for patients with HGPS is less than 13 years. In zebraﬁsh,
investigators were able to use a combination of directed
loss of function mutations and morpholino knockdowns
of prelamin and progerin to generate zebraﬁsh that were
able to live to adulthood (though with shortened lifespans).
These ﬁsh had both phenotypic and molecular signs of
early senescence, including lipodystrophy, aberrant muscu-
lature and craniofacial skeletal structure, increased cellular
apoptosis, and cell-cycle arrest [111]. These phenotypic
manifestations align remarkably well with those seen in
human HGPS, demonstrating a proof of concept for reverse
genetic approaches to developing zebraﬁsh models of human
diseases.
Some of the mutants generated during forward-genetic
screens have been subsequently subjected to drug screening
methodologies. The ability to rapidly and easily image
large numbers of developing zebraﬁsh makes them highly
tractableasapreclinicalsystemfordrugscreens[112].Apro-
totypical example of drug screening in mutant zebraﬁsh dis-
covered with the ENU forward-genetic approaches involves
the gridlock (grl) mutant. The grl mutant lacks blood ﬂow
to the posterior trunk and tail due to a localized block in
caudal blood ﬂow at the base of the dorsal aorta [113].
This model has many characteristics similar to the human
congenital disease coarctation of the aorta, making it of
signiﬁcant clinical interest. Coarctation of the aorta involves
narrowingoftheaortathataﬀects1in2,500livebirths[114].
It is the ﬁfth most common form of congenital heart defect,
and without surgical treatment the mean age of survival is
only 31 years of age [114]. Surgical intervention can prevent
early death, but signiﬁcant morbidity, usually in the form
of hypertension, can persist and results in decreased life
expectancy [114]. Unfortunately, no clear etiology of the8 Journal of Biomedicine and Biotechnology
disease exists, and the grl model in zebraﬁsh is the best
animal model currently in existence for the study of this
disease [114].
The grl zebraﬁsh has a hypomorphic mutation in the
hey2 gene, a basic helix-loop-helix protein involved in aortic
development [115]. Gene titration studies using morpholino
technology demonstrated that dose-dependent loss of this
gene results in ablation of progressively larger sections of the
aorta and expansion of the contiguous region of vein [116].
A pharmacological screen, assessing restoration of blood
ﬂood and survival of larvae using bright-ﬁeld microscopy,
found that two structurally related compounds (GS3999
and GS4012, unknown targets) promoted activation of the
vascular endothelial growth factor (VEGF) pathway and
were able to rescue the phenotype [117]. Another unre-
lated screen found that phosphoinositide-3-kinase (PI3K)
inhibitors were also able to rescue the phenotype by driving
VEGF activation [118]. This included the uncharacterized
ﬂavoneGS4898,astructurallysimilarcompoundtothePI3K
inhibitor LY294002, and the PI3K inhibitor wortmannin.
This work also demonstrated for the ﬁrst time that ERK sig-
naling in embryos drives aortic diﬀerentiation, while activa-
tion of PI3K signaling produces a venous fate. These ﬁndings
have since been recapitulated in a murine system and have
provided new insights into arterial morphogenesis [119]a s
well as generated some of the ﬁrst insights into the underly-
ing mechanisms behind coarctation of the aorta in humans.
A pair of robust screens has also been performed to eval-
uate compounds known to induce prolonged QT intervals in
humans in the hopes of developing a preclinical cardiac toxi-
city screen. Cardiac QT elongation, which can cause the fatal
heart arrhythmia known as Torsade de Pointes, is required
to be evaluated in clinical drug trials [120] and thus these
screens are of great clinical importance. Two such screens to
evaluate bradycardia, atrioventricular blockade and arrhyth-
mias in zebraﬁsh have been performed thus far [121, 122].
In the ﬁrst study 100 biologically active compounds were
screenedand18ofthe23thatcausedarrhythmiasinhumans
were also positive in the zebraﬁsh, while postscreen analysis
showed that poor absorption explained 4 out of 5 of the
false-negatives [122]. Additionally, the combination of ery-
thromycin and cisapride was also positive during screening
while each drug alone was not, recapitulating a known
drug-drug interaction that causes arrhythmias in humans.
Consequently, the zebraﬁsh hold signiﬁcant promise to be
used as a screen to evaluate new drugs for their potential to
generate this serious and often fatal side eﬀect.
6. OverallLimitations
Theuseofzebraﬁshasamodelorganismforstudyinghuman
disease is a relatively new and emerging ﬁeld of research.
Consequently, the number of available zebraﬁsh strains
and facilities that house zebraﬁsh is much smaller than
for well-developed model higher vertebrate organisms such
as the mouse. Additionally, very few validated zebraﬁsh
reagents such as antibodies and cell lines are available to the
research community. This signiﬁcantly curtails the in-depth
investigation of molecular and cellular details implicated in a
given phenotypes.
Zebraﬁsh also have numerous duplicate genes [123],
which signiﬁcantly complicate generation of knockout
strains using either forward or reverse-genetic approaches.
Forward-genetic approaches that disrupt one gene copy
likely will not disrupt the second copy, and duplicate genes
also make targeted knockout strategies more diﬃcult as both
copies must be deleted. Additionally, while the zebraﬁsh
genome has been fully sequenced, the annotation is still
limited and more of a work in progress. Furthermore com-
parative genomic analyses between zebraﬁsh and the human
or murine genome counterparts have yet to be performed.
Zebraﬁsh also have environmental conditions that diﬀer
substantially from humans. They must be raised in water
with speciﬁc ionic concentrations and temperature (28◦C).
Consequently, some water-insoluble small molecules cannot
beadministeredtozebraﬁshbecausecarriersolvents(suchas
EtOH or DMSO) would reach toxic levels before solubility is
achieved. Additionally, since drugs are administered directly
totheﬁshmedia,bathingtheentireﬁshinthetestcompound
can result in nondesired toxic side eﬀects. An example in our
hands was the attempt to use dextran sodium sulfate (DSS)
to induce colitis in larval zebraﬁsh. At concentrations as low
as 0.01% (v/v) the surfactant properties of the DSS choked
the gills of the zebraﬁsh, resulting in their death before an
intestine-speciﬁc eﬀect could be observed (Goldsmith and
Jobin, unpublished observation). As discussed in a previous
section, the development of an oral gavage approach could
circumvent this important limitation.
7.Perspectives
Animalmodelshavebeenusedsincetheinceptionofmedical
research. For most models of human disease, the preferred
and most utilized animal system of human disease is
overwhelmingly the murine system. Despite the tremendous
gain of knowledge provided by using murine experimental
systems, the long gestation time (18–20 days) and sexual
maturation rate (6–8 weeks) combined with high cost
of housing and breeding represent signiﬁcant limitations.
Furthermore, experiments with mice are labor intensive and
not particularly well suited for high-throughput screening.
These limitations have spurred the need to develop other
model organisms that could be used to provide initial gene
or drug targets information before beginning investigations
in more expensive systems.
Transparent, larval zebraﬁsh models have the potential
to ﬁll this important niche in the study of human disease,
enabling rapid, physiologically relevant in vivo screening.
The transparent nature of zebraﬁsh also allows for real-
time imaging of pathogenesis, which has already provided
key insights into the molecular mechanisms of metastasis
[124–127] and tuberculosis dissemination [90–92]. The
recent advent of the Casper ﬁsh promises to extend the
imaging capacity beyond larvae to adult ﬁsh, permitting
studies in ﬁsh with a functional adaptive immune system.
The zebraﬁsh has already demonstrated profound bench-to-
bedside power, as evidenced by the rapid translation timeJournal of Biomedicine and Biotechnology 9
(∼2-years) from the initial reports of the role of H2O2 in
neutrophil chemotaxis during wound healing in zebraﬁsh
[11] to the ﬁrst utilizations of such knowledge in human
patients [18].
The zebraﬁsh remains a relatively underdeveloped model
organismwithlargeamountsofuntappedpotential.Asmore
is understood about the comparative genome, anatomy, and
physiology of zebraﬁsh to that of humans, the relevance and
utility of this vertebrate model will only grow and provide
a powerful complement to the murine system. Two decades
of research has demonstrated the power and relevancy of the
zebraﬁsh in modeling human disease. Its unique properties
make it an ideal in vivo system for initial use in the
interrogation of a given pathology before translating the
observations made in the model organism to more expensive
murine systems.
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